Potentially Inappropriate Antiepileptic Drugs for Elderly Patients with Epilepsy

Journal of the American Geriatrics Society

Volumn 52, Issue 3, 2004, Pages 417-422

  Pugh, Mary Jo V ^a,b   Cramer, Joyce ^c,d   Knoefel, Janice ^c,d,e   Charbonneau, Andrea ^a,f   Mandell, Alan ^b,g   Kazis, Lewis ^h   Berlowitz, Dan ^h  

^a Center for Health Quality Outcomes and Economic Research   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

^d NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^e UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^f BOSTON MEDICAL CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adverse effects; Drug therapy; Epilepsy; Geriatrics; Quality of care

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROATE SEMISODIUM; VALPROIC ACID;

AGED; ARTICLE; CLINICAL PRACTICE; CONSULTATION; CONTROLLED DRUG RELEASE; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DISEASE SEVERITY; DRUG COST; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG METABOLISM; EPILEPSY; FEMALE; GERIATRIC CARE; HEALTH CARE FACILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTPATIENT DEPARTMENT; PATIENT CODING; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; RISK; SIDE EFFECT; SINGLE DRUG DOSE; SOLDIER; STANDARD; TREATMENT INDICATION;

ACETIC ACIDS; AGED; AMINES; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PHENYTOIN; RETROSPECTIVE STUDIES; TRIAZINES;

EID: 1542615066     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52115.x     Document Type: Article

References (30)

1. Cramer JA, Smith DB, Mattson RH et al. A method of quantification for the evaluation of antiepileptic drug therapy. Neurology 1983;33:26-37.
2. Mattson R, Cramer JA, Collins J et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-151.
3. Smith DB, Mattson RH, Cramer JA et al. Results of a nationwide Veterans Administration cooperative study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987;28(Suppl. 3):S50-S58.
4. Mattson R, Cramer JA, Collins JF et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 1992;327:765-771.
5. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58:S21-S26.
6. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Epilepsy in Adults. Edinburg, Scotland: Scottish Intercollegiate Guidelines Network, 2001.
7. Karceski S, Morrell M, Carpenter D. The expert consensus guideline series. Treatment of epilepsy. Epilepsy Behav 2001;2:A1-A50.
8. Brodie MJ, Overstall PW, Giorgi L et al. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-87.
9. Steiner TJ, Dellaportas CI, Findley LJ et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin. Epilepsia 1999;40:601-607.
10. Ramsay RE, Rowan AJ, Slater JD et al. Effect of age on epilepsy and its treatment: Results from the VA Cooperative Study. Epilepsia 1994;35:91A.
11. Lackner TE. Strategies for optimizing antiepileptic drug therapy in elderly people. Pharmacotherapy 2002;22:329-364.
12. Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: Clinical implications. Clin Pharmacokinet 1998;35:49-61.
13. Tallis R, Boon P, Perucca E et al. Epilepsy in elderly people: Management issues. Epileptic Disord 2002;2: 33-40.
14. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in managing epilepsy in the elderly patient. Clin Geriatr 2001;9:47-56.
15. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in elderly patients. Pharmacoepidemiol Pharmacokinetics. Arch Fam Med 1994;3:589-598.
16. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Epilepsy in Adults. Edinburg, Scotland: Scottish Intercollegiate Guidelines Network, 1997.
17. Lipton HL, Bird JA. Drug utilization review in ambulatory settings. State of the science and directions for outcomes research. Med Care 1993;31:1069-1082.
18. Hauser WA. Epidemiology of seizures and epilepsy in the elderly. In: Rowan AJ, ed. Seizures and Epilepsy in the Elderly. Newton, MA: Butterworth-Heinemann, 1997.
19. Haberman SJ. Analysis of Qualitative Data. Burlington, MA: Academic Press, 1979.
20. Willmore LJ. Antiepileptic drug therapy in the elderly. Pharmacol Ther 1998;78:6-16.
21. Rowan AJ. Seizure. Fundamentals of drug management of epilepsy in the older patient. Geriatrics 2002;57:33-37.
22. Martin R, Meador K, Turrentine L et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001;42:764-771.
23. Scheuer ML, Pedley TA. The evaluation and treatment of seizures. N Engl J Med 1990;323:1468-1474.
24. Greer AL. The state of the art versus the state of the science. Int J Technol Assess Health Care 1988;4:5-26.
25. Cramer JA, Mattson RH, Prevey ML et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277.
26. Ensrud KE, Blackwell TL, Mangione CM et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002;50:1629-1637.
27. Aparasu RR. Drug-related-injury visits to hospital emergency departments. Am J Health Syst Pharm 1998;55:1158-1161.
28. Tallis R. Through a glass darkly. Assessing the quality of care of older people using quality of life measures. In: Tallis R, ed. Quality of Life and Quality of Care in Epilepsy: Update 1993. London: Royal Society of Medicine Services, 1993, pp 79-86.
29. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001;135:703-710.
30. Ferlie E, Fitzgerald L, Wood M et al. The diffusion of innovation in healthcare: The impact of professionals. Washington, DC: Healthcare Division of the Academy of Management, 2001.